What's the difference between KSM-66, Sensoril and Shoden? All three are branded ashwagandha extracts, and between them they account for a large share of the human trials behind ashwagandha's reputation. But they aren't interchangeable. KSM-66 is made from the root alone. Sensoril is a water extract of root and leaf. Shoden is a concentrated extract standardised to 35% withanolide glycosides and taken at a much lower dose. Each has its own trials, its own dose range and its own strengths. This guide compares them side by side, explains why the plant part matters for safety, and shows what to check on a label before you choose.
KSM-66 (Ixoreal) is a root-only extract with at least 5% withanolides, tested at 250 to 600 mg a day for stress, cortisol, sleep and strength (Chandrasekhar 2012; Salve 2019; Langade 2019; Wankhede 2015). Sensoril (Natreon) is an aqueous root-and-leaf extract, tested at 500 to 1,000 mg a day, mainly in people with bipolar disorder or schizophrenia and in strength training (Chengappa 2013, 2018; Ziegenfuss 2018). Shoden (Arjuna Natural) is standardised to 35% withanolide glycosides and was tested at 120 to 240 mg for stress and sleep (Lopresti 2019; Deshpande 2020). Milligram doses can't be swapped between them. For general stress and sleep, KSM-66 has the most trials in healthy adults; root-only extracts also avoid open questions about leaf safety.
This article is general information, not medical advice. Ashwagandha isn't suitable for everyone: avoid it in pregnancy, and talk to your doctor first if you have a thyroid or liver condition, an autoimmune disease, or take sedatives, thyroid medication or immunosuppressants.
Why Does the Type of Ashwagandha Extract Matter?
Because "ashwagandha" on a label can mean very different things. The plant, Withania somnifera, contains a family of steroidal compounds called withanolides, and their mix differs between the root and the leaf. Extracts also differ in the solvent used, the plant part, and the percentage of withanolides they're standardised to. A trial result belongs to the extract that was tested, at the dose that was tested.
Quality on the open market is uneven too. A 2026 study tested 25 ashwagandha supplements against the British and US Pharmacopoeia standards. Over 44% failed the British standard and 60% failed the US one. Only 10 met both, and only two of those could be confirmed as made from root, as most labels implied (Avula 2026). Branded extracts don't solve that problem on their own, but they do give you a named, standardised ingredient that you can match to published research.
If you're new to the herb, start with our overview of ashwagandha benefits and research. This article focuses on the extracts themselves.
KSM-66, Sensoril and Shoden at a Glance
The table summarises how the three extracts are described in their own trials. The trial doses are the amounts actually tested, not a recommendation.
| KSM-66 | Sensoril | Shoden | |
|---|---|---|---|
| Maker | Ixoreal | Natreon | Arjuna Natural |
| Plant part | Root only | Root and leaf | Described as a root extract in its 2019 trial |
| Extraction | Water-based | Water-based | Ethanol and water (70:30) |
| Standardisation | At least 5% withanolides | Withanolide glycosides, withaferin A and oligosaccharides | At least 35% withanolide glycosides (HPLC) |
| Daily doses tested | 250–600 mg | 500–1,000 mg | 120–240 mg |
| Main trial areas | Stress, cortisol, sleep, strength | Cognition and symptoms in psychiatric patients, strength | Stress, sleep, hormones in older men |
Sources: Chandrasekhar 2012; Salve 2019; Langade 2019; Wankhede 2015; Chengappa 2013, 2018; Ziegenfuss 2018; Lopresti 2019a, 2019b; Deshpande 2020.
What Does the KSM-66 Research Show?
KSM-66 is the extract behind many of the best-known ashwagandha trials in healthy adults. The papers describe it as a "high-concentration full-spectrum" root extract, and the full texts name KSM-66 and its maker.
- Stress and cortisol. In a 60-day trial of 64 adults with chronic stress, 300 mg twice a day lowered scores on every stress questionnaire used and reduced serum cortisol compared with placebo. Side effects were mild and similar to placebo (Chandrasekhar 2012).
- Dose comparison. A 2019 trial compared 125 mg and 300 mg twice daily (250 and 600 mg a day) with placebo in 60 stressed adults. Both doses reduced perceived stress and serum cortisol, with stronger results at 600 mg, and sleep quality improved too (Salve 2019).
- Sleep. In 60 people with insomnia, 300 mg twice daily for 10 weeks shortened the time taken to fall asleep and improved sleep efficiency, measured with wrist actigraphy, and lowered anxiety scores (Langade 2019).
- Strength training. In 57 young men on an 8-week resistance programme, 300 mg twice daily led to bigger gains in bench-press and leg-extension strength and in arm and chest muscle size than placebo. Testosterone rose more too (Wankhede 2015).
Two cautions apply. Most KSM-66 trials were small, ran for 8 to 10 weeks, and were carried out with materials supplied by the manufacturer. And a 2025 meta-analysis of ashwagandha trials found a clear drop in cortisol but no significant effect on perceived stress once results were pooled (Albalawi 2025). The hormone moved more consistently than how people felt. Our ashwagandha dosage guide covers how these trial doses translate to daily use.
What Does the Sensoril Research Show?
Sensoril is a standardised water extract of ashwagandha root and leaf. Its bioactive components include withanolide glycosides, withaferin A and oligosaccharides (Ziegenfuss 2018). Its best-known trials were carried out in people with psychiatric conditions, which makes them less directly relevant to healthy adults looking for stress support.
- Bipolar disorder. In 60 people with stable bipolar disorder, 500 mg a day for 8 weeks, added to their usual medication, improved working memory, reaction time and a measure of social cognition. Most other cognitive tests didn't change (Chengappa 2013).
- Schizophrenia. In 66 patients having a flare of symptoms, 1,000 mg a day for 12 weeks, added to antipsychotics, reduced negative and general symptoms and perceived stress. Drowsiness, stomach discomfort and loose stools were more common than on placebo (Chengappa 2018).
- Strength training. In 38 recreationally active men, 500 mg a day for 12 weeks gave larger gains in squat and bench-press strength than placebo (Ziegenfuss 2018).
ClinicalTrials.gov records confirm that both Chengappa trials used Sensoril. A 2026 report of standard regulatory toxicology studies on Sensoril found no toxicity or genotoxicity in the tests performed (Summan 2026). That's useful, but it's laboratory and animal safety data, not long-term human data on leaf-containing extracts.
What Does the Shoden Research Show?
Shoden is the most concentrated of the three. In its 2019 stress trial, it was extracted with a 70:30 mix of ethanol and water and standardised by HPLC to at least 35% withanolide glycosides. One 240 mg capsule delivered 84 mg of withanolide glycosides (Lopresti 2019a).
- Stress. In 60 mildly anxious adults, 240 mg once daily for 60 days reduced anxiety scores more than placebo. Morning cortisol fell by 23% on ashwagandha, compared with a 0.5% rise on placebo (Lopresti 2019a).
- Sleep. In 144 healthy adults who reported unrefreshing sleep, 120 mg once daily for six weeks increased self-reported sleep quality by 72%, compared with 29% on placebo (Deshpande 2020).
- Men's hormones. In overweight men aged 40 to 70, a Shoden bead formulation for 8 weeks raised DHEA-S by 18% and testosterone by 14.7% more than placebo, but didn't change cortisol (Lopresti 2019b).
Shoden's low dose comes from its concentration, not from a different plant. 120 to 240 mg of Shoden isn't "less ashwagandha" than 600 mg of KSM-66 in any simple sense; the two are measured in different ways. Sources also differ on Shoden's plant part, so check the label of any product that uses it.
Root vs Leaf: Why Does the Plant Part Matter?
Root and leaf have different chemistry. A 2026 review comparing the evidence found that root is dominated by withanolide A, withanolide D and related glycosides, while leaf is richer in withaferin A and similar reactive withanolides. Several randomised trials and a 12-month study of standardised root extracts showed good tolerability. Human data on leaf, by contrast, are sparse and hard to interpret (Dutta 2026).
That doesn't mean leaf extracts are unsafe. Sensoril, which contains leaf, has been taken for up to 12 weeks in trials without serious problems (Chengappa 2018; Ziegenfuss 2018). But traditional Ayurvedic use centres on the root, and most of the regulatory and safety debate about ashwagandha concerns the leaf and whole-plant preparations. If you'd rather keep to the best-documented option, a root-only extract is the conservative choice.
Plant part also matters for honesty in labelling. Leaf is cheaper, and the pharmacopoeia study above found that many "root" supplements couldn't be confirmed as root-derived (Avula 2026). A named, root-only branded extract is one way to reduce that uncertainty.
Can You Compare Doses Across the Three Extracts?
Not by milligrams. The extracts are standardised to different markers, measured with different methods, and made from different plant parts with different solvents. "5% withanolides" in one extract and "35% withanolide glycosides" in another aren't the same unit, so multiplying a dose by a percentage doesn't give you an equivalent amount.
The practical rule is simple. Take the extract you've chosen at the dose used in its own trials:
- KSM-66: 250 to 600 mg a day, often as 300 mg twice daily.
- Sensoril: 500 mg a day in the healthy-adult strength trial; higher doses were used only in psychiatric patients under supervision.
- Shoden: 120 mg a day for sleep, 240 mg for stress.
If a product just says "ashwagandha extract" with no brand or standardisation, you can't match it to any of these trials. Plain root powder is different again; our dosage guide covers how it compares.
Which Ashwagandha Extract Should You Choose?
It depends on what you want it for, and on how much weight you give the evidence in healthy people. Here's how the trials line up by goal.
- Everyday stress and cortisol: KSM-66 has the most trials in stressed but healthy adults, at 250 to 600 mg. Shoden at 240 mg has one good trial.
- Sleep: both KSM-66 (in insomnia) and Shoden (in unrefreshing sleep) have positive trials. Read more in our article on ashwagandha for sleep.
- Strength training: KSM-66 and Sensoril both improved strength gains in young men alongside a training programme.
- Cognition: Sensoril's cognition data come from people with bipolar disorder, which isn't strong evidence for healthy adults. Our comparison of lion's mane vs ashwagandha looks at the cognition evidence in more detail.
For most healthy adults looking for stress or sleep support, a root-only extract tested at 250 to 600 mg is the best-documented starting point. Whichever you choose, give it 8 weeks, since that's how long most trials ran, and keep the dose within the tested range.
What Are the Side Effects of Ashwagandha Extracts?
In trials of all three extracts, side effects were usually mild: drowsiness, stomach upset and loose stools were the most common (Chandrasekhar 2012; Chengappa 2018). Serious problems are rare but documented. A case series from Iceland and the US Drug-Induced Liver Injury Network described five people who developed jaundice 2 to 12 weeks after starting ashwagandha supplements. None developed liver failure, and liver tests returned to normal within 1 to 5 months in the four who were followed up (Björnsson 2020).
Other cautions apply to every type of extract:
- Pregnancy and breastfeeding: avoid ashwagandha.
- Thyroid conditions: ashwagandha may raise thyroid hormone levels; see ashwagandha and thyroid.
- Sedatives, sleep medication and alcohol: the effects may add up.
- Autoimmune disease or immunosuppressants: ask your doctor first.
- Liver symptoms: stop at once and see a doctor if you develop yellow skin or eyes, dark urine or severe itching.
Our full guide to ashwagandha side effects and liver safety covers the case reports in detail.
What Should You Check on an Ashwagandha Label?
Whether you buy a branded extract or not, these details tell you whether a product can be matched to the research.
- Plant part: "root" or "root and leaf" should be stated. "Whole plant" or no plant part at all is a weaker sign.
- Extract name: a branded ingredient is usually shown with a registered trademark symbol and the brand owner's name. A bare "KSM-66" in a product title, without that detail, doesn't tell you much on its own.
- Standardisation: a withanolide percentage, ideally with the testing method.
- Amount per capsule: so you can match your daily dose to the trial range.
- Batch testing: a certificate of analysis for identity, withanolide content and contaminants such as heavy metals.
Our own ashwagandha capsules contain 500 mg of ashwagandha root extract per capsule, within the dose range used in root-extract trials. If you prefer to measure your own amount, there's also ashwagandha root powder, which isn't standardised. You'll find more stress and sleep options in our herbal and botanical collection.
Frequently Asked Questions
Is KSM-66 or Sensoril better?
Neither is better in every way. KSM-66 is root-only and has more trials in healthy, stressed adults, including for cortisol and sleep. Sensoril is a root-and-leaf extract whose main trials involved people with bipolar disorder or schizophrenia, plus one strength-training study. For general stress, KSM-66 has the stronger evidence base.
What is Shoden ashwagandha?
Shoden is a concentrated ashwagandha extract made by Arjuna Natural, standardised to at least 35% withanolide glycosides. Trials used 240 mg a day for stress and 120 mg for sleep quality, both with positive results compared with placebo (Lopresti 2019a; Deshpande 2020).
Is 300 mg of Shoden the same as 600 mg of KSM-66?
No. The two extracts are standardised to different compounds with different methods, so their milligram doses aren't equivalent. Take each extract at the dose used in its own trials.
Is ashwagandha root or leaf better?
Root has the longer traditional use and most of the human safety data. Leaf contains more withaferin A and has far less human research (Dutta 2026). Root-only extracts are the more conservative choice, though leaf-containing Sensoril was well tolerated in 8- to 12-week trials.
How long does it take for an ashwagandha extract to work?
Most trials measured effects after 6 to 10 weeks. Sleep improvements with Shoden were seen at six weeks, and the KSM-66 stress and insomnia trials ran for 60 days and 10 weeks respectively.
The Bottom Line
KSM-66, Sensoril and Shoden are three different products that share a plant. KSM-66 is root-only and has the most trials in healthy, stressed adults. Sensoril adds leaf and has mostly been studied in psychiatric patients and athletes. Shoden is highly concentrated and works at low doses for stress and sleep. Choose by your goal and by the evidence in people like you, take the dose used in the trials, and prefer a label that tells you the plant part and standardisation.
Related Articles
- Ashwagandha Benefits: What the Research Actually Shows
- Ashwagandha Dosage: How Much to Take Daily
- Does Ashwagandha Help You Sleep?
- Ashwagandha Side Effects and Liver Safety
- Ashwagandha vs Reishi for Stress
Sources
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-62. PubMed 23439798
- Salve J, Pate S, Debnath K, Langade D. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus. 2019;11(12):e6466. PubMed 32021735
- Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus. 2019;11(9):e5797. PubMed 31728244
- Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr. 2015;12:43. PubMed 26609282
- Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder. J Clin Psychiatry. 2013;74(11):1076-83. PubMed 24330893
- Chengappa KNR, Brar JS, Gannon JM, Schlicht PJ. Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study. J Clin Psychiatry. 2018;79(5):17m11826. PubMed 29995356
- Ziegenfuss TN, Kedia AW, Sandrock JE, Raub BJ, Kerksick CM, Lopez HL. Effects of an Aqueous Extract of Withania somnifera on Strength Training Adaptations and Recovery: The STAR Trial. Nutrients. 2018;10(11):1807. PubMed 30463324
- Summan M, Doepker CL, Brorby GP. Safety Evaluation of an Aqueous Root and Leaf Extract of Ashwagandha (Withania somnifera). Phytother Res. 2026;40(8):5030-5047. PubMed 41987003
- Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186. PubMed 31517876
- Lopresti AL, Drummond PD, Smith SJ. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males. Am J Mens Health. 2019;13(2):1557988319835985. PubMed 30854916
- Deshpande A, Irani N, Balkrishnan R, Benny IR. A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults. Sleep Med. 2020;72:28-36. PubMed 32540634
- Albalawi AA. Dual impact of Ashwagandha: Significant cortisol reduction but no effects on perceived stress - A systematic review and meta-analysis. Nutr Health. 2025;31(4):1395-1408. PubMed 40746175
- Dutta A, Gupta JB. Plant Part-Specific Differences in Ashwagandha (Withania somnifera): A Comparative Evaluation of Root and Leaf Evidence for Safety and Regulation. Food Sci Nutr. 2026;14(10):e72364. PubMed 42835472
- Avula B, Katragunta K, Tatapudi KK, Wang YH, Chittiboyina AG, Khan IA. A Comparison of British and US Pharmacopoeia Standards for Quality of Ashwagandha Dietary Supplements in Commerce. Phytother Res. 2026;40(8):4833-4844. PubMed 41386716
- Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829. PubMed 31991029

